Inhibition of MicroRNA-92 alleviates atherogenesis by regulation of macrophage polarization through targeting KLF4. Issue 3 (March 2022)
- Record Type:
- Journal Article
- Title:
- Inhibition of MicroRNA-92 alleviates atherogenesis by regulation of macrophage polarization through targeting KLF4. Issue 3 (March 2022)
- Main Title:
- Inhibition of MicroRNA-92 alleviates atherogenesis by regulation of macrophage polarization through targeting KLF4
- Authors:
- Gao, Feng
Chen, Xueying
Xu, Banglong
Luo, Zhidan
Liang, Yi
Fang, Sihua
Li, Mengli
Wang, Xiaochen
Lin, Xianhe - Abstract:
- Highlights: MiR-92 inhibition promoted macrophage polarization to M2 state in vitro and in vivo. MiR-92 knockdown alleviated plaque size and increased stability. KLF4 was required for miR-92 silencing-mediated macrophage polarization. Abstract: Background: Atherosclerosis is a chronic inflammatory disease in which macrophage polarization plays an important role in contribution to atherosclerotic plaque formation and stability. Here we tested the effect of miR-92 regulation on the development of atherosclerosis beyond tumorigenesis and explored the potential mechanism. Methods and results: In the present study, bone marrow derived macrophages (BMDMs), mouse peritoneal macrophages (MPMs), and human macrophages were used to test the expression of miR-92. Here we noticed miR-92 levels were enhanced in classic M1 macrophage but decreased in alternative M2 macrophage, respectively. In vitro, we demonstrated that macrophages transfected with miR-92 inhibitor attenuated proinflammatory cytokine secretion represented by polarized M1 markers but promoted anti-inflammatory state that was indicative of an M2 phenotype. Mechanistically, miR-92 was found to directly interact with KLF4 and we further identified a requirement role of KLF4 in mediating the effect of miR-92 silencing macrophage polarization. Concomitantly, miR-92 inhibition treated ApoE −/− mice promoted macrophage polarization toward alternative M2 macrophage, thus protecting against atherosclerotic plaque formation andHighlights: MiR-92 inhibition promoted macrophage polarization to M2 state in vitro and in vivo. MiR-92 knockdown alleviated plaque size and increased stability. KLF4 was required for miR-92 silencing-mediated macrophage polarization. Abstract: Background: Atherosclerosis is a chronic inflammatory disease in which macrophage polarization plays an important role in contribution to atherosclerotic plaque formation and stability. Here we tested the effect of miR-92 regulation on the development of atherosclerosis beyond tumorigenesis and explored the potential mechanism. Methods and results: In the present study, bone marrow derived macrophages (BMDMs), mouse peritoneal macrophages (MPMs), and human macrophages were used to test the expression of miR-92. Here we noticed miR-92 levels were enhanced in classic M1 macrophage but decreased in alternative M2 macrophage, respectively. In vitro, we demonstrated that macrophages transfected with miR-92 inhibitor attenuated proinflammatory cytokine secretion represented by polarized M1 markers but promoted anti-inflammatory state that was indicative of an M2 phenotype. Mechanistically, miR-92 was found to directly interact with KLF4 and we further identified a requirement role of KLF4 in mediating the effect of miR-92 silencing macrophage polarization. Concomitantly, miR-92 inhibition treated ApoE −/− mice promoted macrophage polarization toward alternative M2 macrophage, thus protecting against atherosclerotic plaque formation and preventing a vulnerable phenotype. Conclusion: miR-92 inhibition promoted alternative macrophage activation and attenuated atherosclerosis regression partially regulated in a KLF4-dependent manner, which indicated that miR-92/KLF4 axis may serve as a promising strategy for prevention of atherosclerotic diseases. Graphical abstract: We showed herein that miR-92 contributed to the development of atherosclerosis by directly controlling macrophage polarization. Inhibition of miR-92 downregulated markers that represent classical activated macrophages but increased alternative activated macrophages markers. Moreover, miR-92 inhibitor treated ApoE-/- mice fed with HFD leaded to alleviated atherosclerotic plaque size and increased stability characterizes. Mechanistically, miR-92 can directly target KLF4 which was required for the macrophage polarization mediated by miR-92 silencing. Image, graphical abstract … (more)
- Is Part Of:
- Journal of cardiology. Volume 79:Issue 3(2022)
- Journal:
- Journal of cardiology
- Issue:
- Volume 79:Issue 3(2022)
- Issue Display:
- Volume 79, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 79
- Issue:
- 3
- Issue Sort Value:
- 2022-0079-0003-0000
- Page Start:
- 432
- Page End:
- 438
- Publication Date:
- 2022-03
- Subjects:
- miR-92 -- Macrophage polarization -- KLF4 -- Atherosclerosis
Cardiology -- Periodicals
616.12 - Journal URLs:
- http://www.clinicalkey.com/dura/browse/journalIssue/09145087 ↗
http://www.sciencedirect.com/science/journal/09145087 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jjcc.2021.10.015 ↗
- Languages:
- English
- ISSNs:
- 0914-5087
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4954.864200
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20689.xml